{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T07:51:07Z","timestamp":1793865067121,"version":"4.6.1"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T00:00:00Z","timestamp":1581984000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T00:00:00Z","timestamp":1581984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Exposure to thalidomide during a critical window of development results in limb defects in humans and non-human primates while mice and rats are refractory to these effects. Thalidomide-induced teratogenicity is dependent on its binding to cereblon (CRBN), the substrate receptor of the Cul4A-DDB1-CRBN-RBX1 E3 ubiquitin ligase complex. Thalidomide binding to CRBN elicits subsequent ubiquitination and proteasomal degradation of CRBN neosubstrates including SALL4, a transcription factor of which polymorphisms phenocopy thalidomide-induced limb defects in humans. Herein, thalidomide-induced degradation of SALL4 was examined in human induced pluripotent stem cells (hiPSCs) that were differentiated either to lateral plate mesoderm (LPM)-like cells, the developmental ontology of the limb bud, or definitive endoderm. Thalidomide and its immunomodulatory drug (IMiD) analogs, lenalidomide, and pomalidomide, dose-dependently inhibited hiPSC mesendoderm differentiation. Thalidomide- and IMiD-induced SALL4 degradation can be abrogated by CRBN V388I mutation or SALL4 G416A mutation in hiPSCs. Genetically modified hiPSCs expressing CRBN E377V\/V388I mutant or SALL4 G416A mutant were insensitive to the inhibitory effects of thalidomide, lenalidomide, and pomalidomide on LPM differentiation while retaining sensitivity to another known limb teratogen, all-trans retinoic acid (atRA). Finally, disruption of LPM differentiation by atRA or thalidomide perturbed subsequent chondrogenic differentiation <jats:italic>in vitro<\/jats:italic>. The data here show that thalidomide, lenalidomide, and pomalidomide affect stem cell mesendoderm differentiation through CRBN-mediated degradation of SALL4 and highlight the utility of the LPM differentiation model for studying the teratogenicity of new CRBN modulating agents.<\/jats:p>","DOI":"10.1038\/s41598-020-59542-x","type":"journal-article","created":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T11:04:16Z","timestamp":1582023856000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Thalidomide Inhibits Human iPSC Mesendoderm Differentiation by Modulating CRBN-dependent Degradation of SALL4"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2145-3829","authenticated-orcid":false,"given":"David G.","family":"Belair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"Waller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason A.","family":"Gustin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel D.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle L.","family":"Kolaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,18]]},"reference":[{"key":"59542_CR1","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/bdrc.21096","volume":"105","author":"N Vargesson","year":"2015","unstructured":"Vargesson, N. Thalidomide-induced teratogenesis: History and mechanisms. Birth Defects Res. Part C - Embryo Today Rev. 105, 140\u2013156 (2015).","journal-title":"Birth Defects Res. Part C - Embryo Today Rev."},{"key":"59542_CR2","doi-asserted-by":"publisher","first-page":"8573","DOI":"10.1073\/pnas.0901505106","volume":"106","author":"C Therapontos","year":"2009","unstructured":"Therapontos, C., Erskine, L., Gardner, E. R., Figg, W. D. & Vargesson, N. Thalidomide induces limb defects by preventing angiogenic outgrowth during early limb formation. Proc. Natl. Acad. Sci. USA 106, 8573\u20138578 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"59542_CR3","doi-asserted-by":"publisher","first-page":"4082","DOI":"10.1073\/pnas.91.9.4082","volume":"91","author":"RJD Amato","year":"1994","unstructured":"Amato, R. J. D., Loughnan, M. S., Flynn, E. & Folkman, J. Thalidomide is an inhibitor of angiogenesis. Proc. Natl. Acad. Sci. USA 91, 4082\u20134085 (1994).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"59542_CR4","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1124\/mol.64.2.415","volume":"64","author":"L Drucker","year":"2003","unstructured":"Drucker, L. et al. Thalidomide down-regulates transcript levels of GC-rich promoter genes in multiple myeloma. Mol Pharmacol 64, 415\u2013420 (2003).","journal-title":"Mol Pharmacol"},{"key":"59542_CR5","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/S0006-2952(99)00388-3","volume":"59","author":"TD Stephens","year":"2000","unstructured":"Stephens, T. D., Bunde, C. J. & Fillmore, B. J. Mechanism of action in thalidomide teratogenesis. Biochem. Pharmacol. 59, 1489\u20131499 (2000).","journal-title":"Biochem. Pharmacol."},{"key":"59542_CR6","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1126\/science.1177319","volume":"327","author":"T Ito","year":"2010","unstructured":"Ito, T. et al. Identification of a primary target of thalidomide teratogenicity. Science (80-.). 327, 1345\u20131350 (2010).","journal-title":"Science (80-.)."},{"key":"59542_CR7","unstructured":"US FDA. Thalomid(R) [package insert] (2014)."},{"key":"59542_CR8","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/nsmb.2874","volume":"21","author":"PP Chamberlain","year":"2014","unstructured":"Chamberlain, P. P. et al. Structure of the human Cereblon-DDB1-lenalidomide complex reveals basis for responsiveness to thalidomide analogs. Nat. Struct. Mol. Biol. 21, 803\u2013809 (2014).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"59542_CR9","doi-asserted-by":"publisher","first-page":"6187","DOI":"10.1074\/jbc.M117.816868","volume":"293","author":"AA Akuffo","year":"2018","unstructured":"Akuffo, A. A. et al. Ligand-mediated protein degradation reveals functional conservation among sequence variants of the CUL4-type E3 ligase substrate receptor cereblon. J. Biol. Chem. 293, 6187\u20136200 (2018).","journal-title":"J. Biol. Chem."},{"key":"59542_CR10","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/s41589-018-0129-x","volume":"14","author":"ME Matyskiela","year":"2018","unstructured":"Matyskiela, M. E. et al. SALL4 mediates teratogenicity as a thalidomide-dependent cereblon substrate. Nat. Chem. Biol. 14, 981\u2013987 (2018).","journal-title":"Nat. Chem. Biol."},{"key":"59542_CR11","doi-asserted-by":"crossref","unstructured":"Donovan, K. A. et al. Thalidomide promotes degradation of SALL4, a transcription factor implicated in Duane Radial Ray syndrome. 91, 1\u201325 (2018).","DOI":"10.7554\/eLife.38430.045"},{"key":"59542_CR12","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1136\/jmg.40.7.473","volume":"40","author":"J Kohlhase","year":"2003","unstructured":"Kohlhase, J. et al. Mutations at the SALL4 locus on chromosome 20 result in a range of clinically overlapping phenotypes, including Okihiro syndrome, Holt-Oram syndrome, acro-renal-ocular syndrome, and patients previously reported to represent thalidomide embryopathy. J. Med. Genet. 40, 473\u20138 (2003).","journal-title":"J. Med. Genet."},{"key":"59542_CR13","doi-asserted-by":"publisher","first-page":"5075","DOI":"10.1073\/pnas.1421949112","volume":"112","author":"R Akiyama","year":"2015","unstructured":"Akiyama, R. et al. Sall4-Gli3 system in early limb progenitors is essential for the development of limb skeletal elements. Proc. Natl. Acad. Sci. 112, 5075\u20135080 (2015).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"59542_CR14","doi-asserted-by":"crossref","unstructured":"Neubert, R., Merker, H.-J. & Neubert, D. Developmental model for thalidomide action. Nature 400 (1999).","DOI":"10.1038\/22685"},{"key":"59542_CR15","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/24516","volume":"396","author":"CJ Tabin","year":"1998","unstructured":"Tabin, C. J. A developmental model for thalidomide defects. Nature 396, 322\u2013323 (1998).","journal-title":"Nature"},{"key":"59542_CR16","doi-asserted-by":"crossref","unstructured":"Genschow, E. et al. Validation of the Embryonic Stem Cell Test in the International ECVAM Validation Study on Three In Vitro Embryotoxicity Tests. 209\u2013244 (2004).","DOI":"10.1177\/026119290403200305"},{"key":"59542_CR17","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/bdrb.20148","volume":"83","author":"JA Paquette","year":"2008","unstructured":"Paquette, J. A. et al. Assessment of the Embryonic Stem Cell Test and application and use in the pharmaceutical industry. Birth Defects Res. B. Dev. Reprod. Toxicol. 83, 104\u2013111 (2008).","journal-title":"Birth Defects Res. B. Dev. Reprod. Toxicol."},{"key":"59542_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2015.05.009","author":"X Gao","year":"2015","unstructured":"Gao, X., Sprando, R. L. & Yourick, J. J. Thalidomide induced early gene expression perturbations indicative of human embryopathy in mouse embryonic stem cells. Toxicol. Appl. Pharmacol. https:\/\/doi.org\/10.1016\/j.taap.2015.05.009 (2015).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"59542_CR19","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s11626-017-0192-8","volume":"53","author":"S Tachikawa","year":"2017","unstructured":"Tachikawa, S., Nishimura, T., Nakauchi, H. & Ohnuma, K. Thalidomide induces apoptosis in undifferentiated human induced pluripotent stem cells. Vitr. Cell. Dev. Biol. - Anim. 53, 841\u2013851 (2017).","journal-title":"Vitr. Cell. Dev. Biol. - Anim."},{"key":"59542_CR20","first-page":"201","volume":"207","author":"N Aikawa","year":"2014","unstructured":"Aikawa, N. et al. Detection of Thalidomide Embryotoxicity by In Vitro Embryotoxicity Testing Based on Human iPS. Cells. 207, 201\u2013207 (2014).","journal-title":"Cells."},{"key":"59542_CR21","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s11626-018-0234-x","volume":"54","author":"S Tachikawa","year":"2018","unstructured":"Tachikawa, S., Shimizu, M., Maruyama, K. & Ohnuma, K. Thalidomide induces apoptosis during early mesodermal differentiation of human induced pluripotent stem cells. Vitr. Cell. Dev. Biol. - Anim. 54, 231\u2013240 (2018).","journal-title":"Vitr. Cell. Dev. Biol. - Anim."},{"key":"59542_CR22","doi-asserted-by":"publisher","unstructured":"Xing, J., Toh, Y., Xu, S. & Yu, H. A method for human teratogen detection by geometrically confined cell differentiation and migration. Nat. Publ. Gr. 1\u201313, https:\/\/doi.org\/10.1038\/srep10038 (2015).","DOI":"10.1038\/srep10038"},{"key":"59542_CR23","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/toxsci\/kft239","volume":"137","author":"S Kameoka","year":"2014","unstructured":"Kameoka, S., Babiarz, J., Kolaja, K. & Chiao, E. A High-Throughput Screen for Teratogens Using Human Pluripotent Stem Cells. Toxicol. Sci. 137, 76\u201390 (2014).","journal-title":"Toxicol. Sci."},{"key":"59542_CR24","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/dgd.12017","volume":"55","author":"M Tanaka","year":"2013","unstructured":"Tanaka, M. Molecular and evolutionary basis of limb field specification and limb initiation. Dev. Growth Differ. 55, 149\u2013163 (2013).","journal-title":"Dev. Growth Differ."},{"key":"59542_CR25","doi-asserted-by":"publisher","unstructured":"Shimizu, H., Yokoyama, S. & Asahara, H. Growth and differentiation of the developing limb bud from the perspective of chondrogenesis. 449\u2013454, https:\/\/doi.org\/10.1111\/j.1440-169x.2007.00945.x (2007).","DOI":"10.1111\/j.1440-169x.2007.00945.x"},{"key":"59542_CR26","first-page":"1","volume":"3","author":"Y Chen","year":"2017","unstructured":"Chen, Y., Xu, H. & Lin, G. Generation of iPSC-derived limb progenitor-like cells for stimulating phalange regeneration in the adult mouse. Cell Discov. 3, 1\u201314 (2017).","journal-title":"Cell Discov."},{"key":"59542_CR27","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1089\/scd.2012.0590","volume":"22","author":"JY Tan","year":"2013","unstructured":"Tan, J. Y., Sriram, G., Rufaihah, A. J., Neoh, K. G. & Cao, T. Efficient Derivation of Lateral Plate and Paraxial Mesoderm Subtypes from Human Embryonic Stem Cells Through GSKi-Mediated Differentiation. Stem Cells Dev. 22, 1893\u20131906 (2013).","journal-title":"Stem Cells Dev."},{"key":"59542_CR28","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1681\/ASN.2013080831","volume":"25","author":"AQ Lam","year":"2014","unstructured":"Lam, A. Q. et al. Rapid and Efficient Differentiation of Human Pluripotent Stem Cells into Intermediate Mesoderm That Forms Tubules Expressing Kidney Proximal Tubular Markers. J. Am. Soc. Nephrol. 25, 1211\u20131225 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"59542_CR29","doi-asserted-by":"publisher","unstructured":"Mori, S., Sakakura, E., Eiraku, M., Tsunekawa, Y. & Hagiwara, M. Self-organized formation of developing appendages from murine pluripotent stem cells. Nat. Commun. 1\u201313, https:\/\/doi.org\/10.1038\/s41467-019-11702-y (2019).","DOI":"10.1038\/s41467-019-11702-y"},{"key":"59542_CR30","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nbt.1754","volume":"29","author":"JT Robinson","year":"2011","unstructured":"Robinson, J. T. et al. Integrative Genomics Viewer James. Nat. Biotechnol. 29, 24\u201326 (2011).","journal-title":"Nat. Biotechnol."},{"key":"59542_CR31","doi-asserted-by":"publisher","unstructured":"Schmid-burgk, J. L. et al. OutKnocker: a web tool for rapid and simple genotyping of designer nuclease edited cell lines. 1719\u20131723, https:\/\/doi.org\/10.1101\/gr.176701.114.24 (2014).","DOI":"10.1101\/gr.176701.114.24"},{"key":"59542_CR32","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.cell.2010.12.032","volume":"144","author":"C Bock","year":"2012","unstructured":"Bock, C. et al. Reference Maps of Human ES and iPS Cell Variation Enable High-Throughput Characterization of Pluripotent Cell Lines. Cell 144, 439\u2013452 (2012).","journal-title":"Cell"},{"key":"59542_CR33","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/0304-4165(86)90306-5","volume":"883","author":"RW Farndale","year":"1986","unstructured":"Farndale, R. W., Buttle, D. J. & Barrett, A. J. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. BBA - Gen. Subj. 883, 173\u2013177 (1986).","journal-title":"BBA - Gen. Subj."},{"key":"59542_CR34","doi-asserted-by":"crossref","unstructured":"Hoemann, C. D., Sun, J., Chrzanowski, V. & Buschmann, M. D. A Multivalent Assay to Detect Glycosaminoglycan, Protein, Collagen, RNA, and DNA Content in Milligram Samples of Cartilage or Hydrogel-Based Repair Cartilage. 10, 1\u201310 (2002).","DOI":"10.1006\/abio.2001.5436"},{"key":"59542_CR35","doi-asserted-by":"publisher","first-page":"30998","DOI":"10.1074\/jbc.M204527200","volume":"277","author":"CN Bennett","year":"2002","unstructured":"Bennett, C. N. et al. Regulation of Wnt Signaling during Adipogenesis. J. Biol. Chem. 277, 30998\u201331004 (2002).","journal-title":"J. Biol. Chem."},{"key":"59542_CR36","doi-asserted-by":"publisher","unstructured":"Rojas, A. et al. Gata4 expression in lateral mesoderm is downstream of BMP4 and is activated directly by Forkhead and GATA transcription factors through a distal enhancer element. 3405\u20133417, https:\/\/doi.org\/10.1242\/dev.01913 (2005).","DOI":"10.1242\/dev.01913"},{"key":"59542_CR37","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1242\/dev.128.2.155","volume":"128","author":"M Mahlapuu","year":"2001","unstructured":"Mahlapuu, M., Ormestad, M., Enerback, S. & Carlsson, P. The forkhead transcription factor Foxf1 is required for differentiation of extra-embryonic and lateral plate mesoderm. Development 128, 155\u2013166 (2001).","journal-title":"Development"},{"key":"59542_CR38","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1242\/dev.126.6.1305","volume":"126","author":"PH Francis-West","year":"1999","unstructured":"Francis-West, P. H. et al. Mechanisms of GDF-5 action during skeletal development. Development 126, 1305\u20131315 (1999).","journal-title":"Development"},{"key":"59542_CR39","doi-asserted-by":"publisher","unstructured":"Faial, T. et al. Brachyury and SMAD signalling collaboratively orchestrate distinct mesoderm and endoderm gene regulatory networks in differentiating human embryonic stem cells. Development 1\u201315, https:\/\/doi.org\/10.1242\/dev.117838 (2015).","DOI":"10.1242\/dev.117838"},{"key":"59542_CR40","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/nature14610","volume":"523","author":"J Kr\u00f6nke","year":"2015","unstructured":"Kr\u00f6nke, J. et al. Lenalidomide induces ubiquitination and degradation of CK1\u03b1 in del(5q) MDS. Nature 523, 183\u2013188 (2015).","journal-title":"Nature"},{"key":"59542_CR41","doi-asserted-by":"publisher","first-page":"11802","DOI":"10.1073\/pnas.1814446115","volume":"115","author":"Y Gemechu","year":"2018","unstructured":"Gemechu, Y. et al. Humanized cereblon mice revealed two distinct therapeutic pathways of immunomodulatory drugs. Proc. Natl. Acad. Sci. 115, 11802\u201311807 (2018).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"59542_CR42","doi-asserted-by":"publisher","unstructured":"Vargesson, N. The teratogenic effects of thalidomide on limbs, https:\/\/doi.org\/10.1177\/1753193418805249 (2019).","DOI":"10.1177\/1753193418805249"},{"key":"59542_CR43","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1182\/blood-2016-09-738500","volume":"129","author":"T Hideshima","year":"2017","unstructured":"Hideshima, T. et al. p53-related protein kinase confers poor prognosis and represents a novel therapeutic target in multiple myeloma. Blood 129, 1308\u20131319 (2017).","journal-title":"Blood"},{"key":"59542_CR44","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1242\/dev.065938","volume":"139","author":"M Rhinn","year":"2012","unstructured":"Rhinn, M. & Doll\u00e9, P. Retinoic acid signalling during development. Development 139, 843\u2013858 (2012).","journal-title":"Development"},{"key":"59542_CR45","doi-asserted-by":"publisher","first-page":"13668","DOI":"10.1073\/pnas.1200872109","volume":"109","author":"LMY Lee","year":"2012","unstructured":"Lee, L. M. Y. et al. A paradoxical teratogenic mechanism for retinoic acid. Proc. Natl. Acad. Sci. 109, 13668\u201313673 (2012).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"59542_CR46","doi-asserted-by":"publisher","first-page":"16806","DOI":"10.1073\/pnas.0603916103","volume":"103","author":"P Gadue","year":"2006","unstructured":"Gadue, P., Huber, T. L., Paddison, P. J. & Keller, G. M. Wnt and TGFb signaling are required for the induction of an in vitro model of primitive streak formation using embryonic stem cells. Proc. Natl. Acad. Sci. 103, 16806\u201316811 (2006).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"59542_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.reprotox.2019.10.001","volume":"91","author":"KS Saili","year":"2020","unstructured":"Saili, K. S. et al. Molecular characterization of a toxicological tipping point during human stem cell di ff erentiation. Reprod. Toxicol. 91, 1\u201313 (2020).","journal-title":"Reprod. Toxicol."},{"key":"59542_CR48","doi-asserted-by":"publisher","first-page":"eaat0572","DOI":"10.1126\/science.aat0572","volume":"362","author":"QL Sievers","year":"2018","unstructured":"Sievers, Q. L. et al. Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBN. Science (80-.). 362, eaat0572 (2018).","journal-title":"Science (80-.)."},{"key":"59542_CR49","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1242\/dev.027748","volume":"136","author":"Y Kawakami","year":"2009","unstructured":"Kawakami, Y. et al. Sall genes regulate region-specific morphogenesis in the mouse limb by modulating Hox activities. Development 136, 585\u2013594 (2009).","journal-title":"Development"},{"key":"59542_CR50","doi-asserted-by":"publisher","unstructured":"Asatsuma-Okumura, T. et al. p63 is a cereblon substrate involved in thalidomide teratogenicity. Nat. Chem. Biol. 1077\u20131084, https:\/\/doi.org\/10.1038\/s41589-019-0366-7 (2019).","DOI":"10.1038\/s41589-019-0366-7"},{"key":"59542_CR51","unstructured":"Walker, L. M., Mcclelland-descalzo, D. L. V & Nieden, N. I. Chapter 4 Embryonic Stem Cells. 1797, 97\u2013124."},{"key":"59542_CR52","doi-asserted-by":"crossref","unstructured":"Scholz, G. & Genschow, E. Embryotoxicity Screening Using Embryonic Stem Cells in vitro: Correlation to in vivo Teratogenicity. 203\u2013211 (1999).","DOI":"10.1159\/000016700"},{"key":"59542_CR53","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1038\/nprot.2011.348","volume":"6","author":"AEM Seiler","year":"2011","unstructured":"Seiler, A. E. M. & Spielmann, H. The validated embryonic stem cell test to predict embryotoxicity in vitro. Nat. Protoc. 6, 961\u2013978 (2011).","journal-title":"Nat. Protoc."},{"key":"59542_CR54","unstructured":"US FDA. Pomalyst(R) [package insert] (2017)."},{"key":"59542_CR55","unstructured":"US FDA. Revlimid(R) [package insert] (2005)."},{"key":"59542_CR56","doi-asserted-by":"crossref","unstructured":"Zhang, J. et al. Sall4 modulates embryonic stem cell pluripotency and early embryonic development by the transcriptional regulation of Pou5f1. Development 8 (2006).","DOI":"10.1038\/ncb1481"},{"key":"59542_CR57","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1111\/j.1537-2995.2012.03888.x","volume":"53","author":"C Gao","year":"2013","unstructured":"Gao, C. et al. SALL4 is a key transcription regulator in normal human hematopoiesis. Transfusion 53, 1037\u20131049 (2013).","journal-title":"Transfusion"},{"key":"59542_CR58","first-page":"543","volume":"3","author":"CY Lim","year":"2008","unstructured":"Lim, C. Y. et al. Sall4 Regulates Distinct Transcription Circuitries in Different Blastocyst-Derived Stem Cell Lineages. Stem Cell 3, 543\u2013554 (2008).","journal-title":"Stem Cell"},{"key":"59542_CR59","doi-asserted-by":"publisher","unstructured":"Yang, L. et al. The stem cell factor SALL4 is an essential transcriptional regulator in mixed lineage leukemia-rearranged leukemogenesis. 1\u201315, https:\/\/doi.org\/10.1186\/s13045-017-0531-y (2017).","DOI":"10.1186\/s13045-017-0531-y"},{"key":"59542_CR60","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.1242\/dev.139113","volume":"3","author":"A Miller","year":"2016","unstructured":"Miller, A. et al. Sall4 controls differentiation of pluripotent cells independently of the Nucleosome Remodelling and Deacetylation (NuRD) complex. Development 3, 3074\u20133084 (2016).","journal-title":"Development"},{"key":"59542_CR61","doi-asserted-by":"crossref","unstructured":"Hoffmann, A. D. et al. Foxf Genes Integrate Tbx5 and Hedgehog Pathways in the Second Heart Field for Cardiac Septation. 10 (2014).","DOI":"10.1371\/journal.pgen.1004604"},{"key":"59542_CR62","doi-asserted-by":"crossref","unstructured":"Li, Y., Zhang, H., Choi, S. C., Litingtung, Y. & Chiang, C. Sonic hedgehog signaling regulates Gli3 processing, mesenchymal proliferation, and differentiation during mouse lung organogenesis. 270, 214\u2013231 (2004).","DOI":"10.1016\/j.ydbio.2004.03.009"},{"key":"59542_CR63","doi-asserted-by":"publisher","unstructured":"Jakobsen, J. S. et al. Temporal ChIP-on-chip reveals Biniou as a universal regulator of the visceral muscle transcriptional network. Genes Dev. 2448\u20132460, https:\/\/doi.org\/10.1101\/gad.437607 (2007).","DOI":"10.1101\/gad.437607"},{"key":"59542_CR64","doi-asserted-by":"publisher","unstructured":"Prosser, A., Scotchford, C., Roberts, G., Grant, D. & Sottile, V. Integrated Multi-Assay Culture Model for Stem Cell Chondrogenic Differentiation, https:\/\/doi.org\/10.3390\/ijms20040951 (2019).","DOI":"10.3390\/ijms20040951"},{"key":"59542_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-016-0028-x","volume":"7","author":"AW Xie","year":"2017","unstructured":"Xie, A. W. et al. Controlled Self-assembly of Stem Cell Aggregates Instructs Pluripotency and Lineage Bias. Sci. Rep. 7, 1\u201315 (2017).","journal-title":"Sci. Rep."},{"key":"59542_CR66","doi-asserted-by":"publisher","unstructured":"Gandhi, J. K. et al. Human Fibrinogen for Maintenance and Differentiation of Induced Pluripotent Stem Cells in Two Dimensions and Three Dimensions. Stem Cells Transl. Med, https:\/\/doi.org\/10.1002\/sctm.18-0189 (2019).","DOI":"10.1002\/sctm.18-0189"},{"key":"59542_CR67","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.biomaterials.2015.12.011","volume":"83","author":"P Kerscher","year":"2016","unstructured":"Kerscher, P. et al. Direct Hydrogel Encapsulation of Pluripotent Stem Cells Enables Ontomimetic Differentiation and Growth of Engineered Human Heart Tissues. Biomaterials 83, 383\u2013395 (2016).","journal-title":"Biomaterials"},{"key":"59542_CR68","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1089\/scd.2013.0111","volume":"23","author":"K Hynes","year":"2014","unstructured":"Hynes, K., Menicanin, D., Mrozik, K., Gronthos, S. & Bartold, P. M. Generation of Functional Mesenchymal Stem Cells from Different Induced Pluripotent Stem Cell Lines. Stem Cells Dev. 23, 1084\u20131096 (2014).","journal-title":"Stem Cells Dev."},{"key":"59542_CR69","doi-asserted-by":"crossref","unstructured":"Craft, A. M. et al. Generation of articular chondrocytes from human pluripotent stem cells. Nat. Biotechnol. 33 (2015).","DOI":"10.1038\/nbt.3210"},{"key":"59542_CR70","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.stemcr.2018.06.021","volume":"11","author":"JY Lee","year":"2018","unstructured":"Lee, J. Y. et al. Pre-transplantational Control of the Post-transplantational Fate of Human Pluripotent Stem Cell-Derived Cartilage. Stem Cell Reports 11, 440\u2013453 (2018).","journal-title":"Stem Cell Reports"},{"key":"59542_CR71","doi-asserted-by":"publisher","unstructured":"Adkar, S. S. et al. Step-Wise Chondrogenesis of Human Induced Pluripotent Stem Cells and Purification Via a Reporter Allele Generated by CRISPR-Cas9 Genome Editing. Stem Cells, https:\/\/doi.org\/10.1002\/stem.240 (2018).","DOI":"10.1002\/stem.240"},{"key":"59542_CR72","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrd.2016.211","volume":"16","author":"AC Lai","year":"2017","unstructured":"Lai, A. C. & Crews, C. M. Induced protein degradation: An emerging drug discovery paradigm. Nat. Rev. Drug Discov. 16, 101\u2013114 (2017).","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-59542-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-59542-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-59542-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T06:53:03Z","timestamp":1670309583000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-59542-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,18]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["59542"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-59542-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,18]]},"assertion":[{"value":"12 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.G.B., G.L., N.D.C. and K.L.K. are employed by Celgene Corporation. L.E.W. and J.A.G. are employed by MilliporeSigma.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2864"}}